| 2024 |
Sullivan, T. R., Morris, T. P., Kahan, B. C., Cuthbert, A. R., & Yelland, L. N. (2024). Categorisation of continuous covariates for stratified randomisation: How should we adjust?. Statistics in Medicine, 43(11), 2083-2095.
DOI |
| 2024 |
Gould, J. F., Cuthbert, A. R., Yelland, L. N., Gibson, R. A., Smithers, L. G., Zhou, S. J., & Makrides, M. (2024). Association of cord blood vitamin D with child neurodevelopment at 7 years of age. Journal of Paediatrics and Child Health, 60(7), 312-322.
DOI |
| 2024 |
Gould, J. F., Gibson, R. A., Yelland, L. N., Colombo, J., McPhee, A. J., Gallier, S., . . . Makrides, M. (2024). Infant formula supplemented with milk fat globule membrane compared with standard infant formula for the cognitive development of healthy term-born formula-fed infants: protocol for a randomised controlled trial. BMJ Open, 14(6), e083399-1-e083399-13.
DOI |
| 2024 |
Lange, K. M., Sullivan, T. R., Kasza, J., & Yelland, L. N. (2024). Performance of mixed effects models and generalized estimating equations for continuous outcomes in partially clustered trials including both independent and paired data. Statistics in Medicine, 43(25), 17 pages.
DOI |
| 2023 |
Lange, K. M., Kasza, J., Sullivan, T. R., & Yelland, L. N. (2023). Partially clustered designs for clinical trials: Unifying existing designs using consistent terminology. Clinical Trials, 20(2), 99-110.
DOI Scopus5 WoS2 Europe PMC1 |
| 2023 |
Yelland, L. N., Sullivan, T. R., Gibson, R. A., Simmonds, L. A., Thakkar, S. K., Huang, F., . . . Makrides, M. (2023). Identifying women who may benefit from higher dose omega-3 supplementation during pregnancy to reduce their risk of prematurity: exploratory analyses from the ORIP trial.. BMJ Open, 13(4), e070220.
DOI Scopus2 Europe PMC2 |
| 2023 |
Best, K. P., Yelland, L. N., Collins, C. T., McPhee, A. J., Rogers, G. B., Choo, J., . . . Makrides, M. (2023). Growth of late preterm infants fed nutrient-enriched formula to 120 days corrected age-A randomized controlled trial.. Frontiers in pediatrics, 11, 1146089.
DOI Europe PMC1 |
| 2023 |
Yelland, L. N., Louise, J., Kahan, B. C., Morris, T. P., Lee, K. J., & Sullivan, T. R. (2023). Handling misclassified stratification variables in the analysis of randomised trials with continuous outcomes. Statistics in Medicine, 42(19), 1-18.
DOI Scopus2 WoS1 Europe PMC2 |
| 2023 |
Sullivan, T. R., Yelland, L. N., Gibson, R. A., Thakkar, S. K., Huang, F., Best, K. P., . . . Makrides, M. (2023). Predictors of compliance with higher dose omega-3 fatty acid supplementation during pregnancy and implications for the risk of prematurity: exploratory analysis of the ORIP randomised trial. BMJ Open, 13(9), e076507-1-e076507-8.
DOI Scopus1 Europe PMC1 |
| 2022 |
Yelland, L. N., Scurrah, K. J., Ferreira, P., Calais-Ferreira, L., Rankin, M., Denton, J., . . . Craig, J. M. (2022). Conducting clinical trials in twin populations: a review of design, analysis, recruitment and ethical issues for twin-only trials. Twin Research and Human Genetics, 24(6), 359-364.
DOI Scopus2 Europe PMC2 |
| 2022 |
Gibson, R. A., Makrides, M., Sullivan, T., Yelland, L. N., & Best, K. P. (2022). Response to Jackson and Harris, 2022;179:102417. Prostaglandins, Leukotrienes and Essential Fatty Acids, 182, 102454.
DOI Scopus1 Europe PMC1 |
| 2022 |
Gould, J. F., Yelland, L. N., Gibson, R. A., McPhee, A. J., Varghese, J., Grivell, R., & Makrides, M. (2022). Protocol for a multicentre prospective observational study of families with full-term infants on postnatal wards and in the community to capture feeding practices across the first year of life: the Mother Infant Lactation Questionnaire (MILQ) study. BMJ Open, 12(10), e066355-1-e066355-6.
DOI Scopus2 Europe PMC2 |
| 2021 |
Chan, K., Gallant, J., Leemaqz, S., Baldwin, D. A., Borath, M., Kroeun, H., . . . Whitfield, K. C. (2021). Assessment of salt intake to consider salt as a fortification vehicle for thiamine in Cambodia. Annals of the New York Academy of Sciences, 1498(1), 85-95.
DOI Scopus7 WoS5 Europe PMC6 |
| 2021 |
Wassie, M. M., Smithers, L. G., Yelland, L. N., Makrides, M., & Zhou, S. J. (2021). Associations between newborn thyroid stimulating hormone concentration and neurodevelopment and growth of children at 18 months. The British Journal of Nutrition, 126(10), 1478-1488.
DOI Scopus3 Europe PMC2 |
| 2021 |
Gallant, J., Chan, K., Green, T. J., Wieringa, F. T., Leemaqz, S., Ngik, R., . . . Whitfield, K. C. (2021). Low-dose thiamine supplementation of lactating Cambodian mothers improves human milk thiamine concentrations: a randomized controlled trial. American Journal of Clinical Nutrition, 114(1), 90-100.
DOI Scopus11 WoS6 Europe PMC9 |
| 2021 |
Sullivan, T. R., Yelland, L. N., Moreno-Betancur, M., & Lee, K. J. (2021). Multiple imputation for handling missing outcome data in randomized trials involving a mixture of independent and paired data. Statistics in Medicine, 40(27), 6008-6020.
DOI Scopus5 WoS4 Europe PMC2 |
| 2021 |
Gould, J. F., Anderson, P. J., Yelland, L. N., Gibson, R. A., & Makrides, M. (2021). The influence of Prenatal DHA supplementation on individual domains of behavioral functioning in school‐aged children: Follow‐up of a randomized controlled trial. Nutrients, 13(9), 2996-1-2996-20.
DOI Scopus3 WoS2 Europe PMC3 |
| 2021 |
Simmonds, L. A., Yelland, L. N., Best, K. P., Liu, G., Gibson, R. A., & Makrides, M. (2021). Translating n-3 polyunsaturated fatty acid status from whole blood to plasma and red blood cells during pregnancy: Translating n-3 status across blood fractions in pregnancy.. Prostaglandins, Leukotrienes and Essential Fatty Acids, 176, 102367.
DOI Scopus7 WoS6 Europe PMC2 |
| 2020 |
Ramsden, C. E., Makrides, M., Yuan, Z. -X., Horowitz, M. S., Zamora, D., Yelland, L. N., . . . Gibson, R. A. (2020). Plasma oxylipins and unesterified precursor fatty acids are altered by DHA supplementation in pregnancy: can they help predict risk of preterm birth?. Prostaglandins, Leukotrienes and Essential Fatty Acids, 153, 102041-1-102041-9.
DOI Scopus17 WoS15 Europe PMC9 |
| 2020 |
Simmonds, L. A., Sullivan, T. R., Skubisz, M., Middleton, P. F., Best, K. P., Yelland, L. N., . . . Makrides, M. (2020). Omega-3 fatty acid supplementation in pregnancy - baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology, 127(8), 975-981.
DOI Scopus67 WoS45 Europe PMC34 |
| 2020 |
Samson, K. L. I., Loh, S. P., Khor, G. L., Mohd Shariff, Z., Yelland, L. N., Leemaqz, S., . . . Karakochuk, C. D. (2020). Effect of once weekly folic acid supplementation on erythrocyte folate concentrations in women to determine potential to prevent neural tube defects: a randomised controlled dose-finding trial in Malaysia.. BMJ open, 10(2), e034598.
DOI Scopus5 WoS4 Europe PMC3 |
| 2020 |
Makrides, M., Best, K., Yelland, L., McPhee, A., Zhou, S., Quinlivan, J., . . . Gibson, R. (2020). A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery. Obstetrical and Gynecological Survey, 75(2), 79-80.
DOI |
| 2020 |
Hewawasam, E., Collins, C. T., Muhlhausler, B. S., Yelland, L. N., Smithers, L. G., Colombo, J. C., . . . Gould, J. F. (2020). Docosahexaenoic acid supplementation in infants born preterm and the effect on attention at 18 months' corrected age: follow-up of a subset of the N3RO randomised controlled trial. The British Journal of Nutrition, 125(4), 1-26.
DOI Scopus15 WoS10 Europe PMC7 |
| 2020 |
Best, K. P., Gibson, R. A., Yelland, L. N., Leemaqz, S., Gomersall, J., Liu, G., & Makrides, M. (2020). Effect of omega-3 lcpufa supplementation on maternal fatty acid and oxylipin concentrations during pregnancy. Prostaglandins Leukot Essent Fatty Acids, 162, 102181-1-102181-9.
DOI Scopus7 WoS6 Europe PMC4 |
| 2020 |
Gawlik, N. R., Makrides, M., Kettler, L., Yelland, L. N., Leemaqz, S., & Gould, J. F. (2020). The influence of DHA supplementation during pregnancy on language development across childhood: follow-up of a randomised controlled trial. Prostaglandins, Leukotrienes and Essential Fatty Acids, 163, 102207-1-102207-12.
DOI Scopus2 WoS2 Europe PMC2 |
| 2020 |
Samson, K. L. I., Loh, S. P., Lee, S. S., Sulistyoningrum, D. C., Khor, G. L., Shariff, Z. B. M., . . . Green, T. J. (2020). Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia.. BMJ Glob Health, 5(12), 1-9.
DOI Scopus11 WoS8 Europe PMC4 |
| 2019 |
Whitfield, K. C., Kroeun, H., Green, T., Wieringa, F. T., Borath, M., Sophonneary, P., . . . Gallant, J. (2019). Thiamine dose response in human milk with supplementation among lactating women in Cambodia: study protocol for a double-blind, four-parallel arm randomised controlled trial. BMJ Open, 9(7), e029255-1-e029255-9.
DOI Scopus8 WoS6 Europe PMC6 |
| 2019 |
Wassie, M. M., Yelland, L. N., Smithers, L. G., Ranieri, E., & Zhou, S. J. (2019). Comparison of iodine status pre- and post-mandatory iodine fortification of bread in South Australia: a population study using newborn thyroid-stimulating hormone concentration as a marker. Public Health Nutrition, 22(16), 3063-3072.
DOI Scopus4 WoS4 Europe PMC2 |
| 2019 |
Makrides, M., Best, K., Yelland, L., McPhee, A., Zhou, S., Quinlivan, J., . . . Gibson, R. (2019). A randomized trial of prenatal n-3 fatty acid supplementation and preterm delivery. The New England journal of medicine, 381(11), 1035-1045.
DOI Scopus69 WoS52 Europe PMC29 |
| 2018 |
Sumathipala, A., Yelland, L., Green, D., Shepherd, T., Jayaweera, K., Ferreira, P., & Craig, J. (2018). Twins as participants in randomized controlled trials: a review of published literature. Twin Research and Human Genetics, 21(1), 51-56.
DOI Scopus11 WoS7 Europe PMC5 |
| 2018 |
Dodd, J., McPhee, A., Deussen, A., Louise, J., Yelland, L., Owens, J., & Robinson, J. (2018). Effects of an antenatal dietary intervention in overweight and obese women on 6 month infant outcomes: follow-up from the LIMIT randomised trial. International Journal of Obesity, 42(7), 1326-1335.
DOI Scopus18 WoS21 Europe PMC9 |
| 2018 |
Yelland, L., Kahan, B., Dent, E., Lee, K., Voysey, M., Forbes, A., & Cook, J. (2018). Prevalence and reporting of recruitment, randomisation and treatment errors in clinical trials: a systematic review. Clinical Trials, 15(3), 278-285.
DOI Scopus15 WoS10 Europe PMC8 |
| 2018 |
Yelland, L., Sullivan, T., Collins, C., Price, D., Mcphee, A., & Lee, K. (2018). Accounting for twin births in sample size calculations for randomised trials. Paediatric and Perinatal Epidemiology, 32(4), 380-387.
DOI Scopus10 WoS7 Europe PMC5 |
| 2018 |
Yelland, L. N., Schuit, E., Zamora, J., Middleton, P. F., Lim, A. C., Nassar, A. H., . . . Gates, S. (2018). Correlation between neonatal outcomes of twins depends on the outcome: secondary analysis of twelve randomised controlled trials. BJOG, 125(11), 1406-1413.
DOI Scopus6 WoS5 Europe PMC5 |
| 2017 |
Lei, Y., Carlson, S., Yelland, L., Makrides, M., Gibson, R., & Gajewski, B. (2017). Comparison of dichotomized and distributional approaches in rare event clinical trial design: a fixed Bayesian design. Journal of Applied Statistics, 44(8), 1466-1478.
DOI Scopus4 WoS3 Europe PMC2 |
| 2017 |
Gould, J. F., Anderson, A. J., Yelland, L. N., Smithers, L. G., Skeaff, C. M., Zhou, S. J., . . . Makrides, M. (2017). Association of cord blood vitamin D with early childhood growth and neurodevelopment. Journal of Paediatrics and Child Health, 53(1), 75-83.
DOI Scopus45 WoS35 Europe PMC31 |
| 2017 |
Yelland, L., Sullivan, T., Price, D., & Lee, K. (2017). Sample size calculations for randomised trials including both independent and paired data. Statistics in Medicine, 36(8), 1227-1239.
DOI Scopus16 WoS13 Europe PMC9 |
| 2017 |
Moran, L., Fraser, L., Sundernathan, T., Deussen, A., Louise, J., Yelland, L., . . . Dodd, J. (2017). The effect of an antenatal lifestyle intervention in overweight and obese women on circulating cardiometabolic and inflammatory biomarkers: secondary analyses from the LIMIT randomised trial. BMC Medicine, 15(1), 1-12.
DOI Scopus15 WoS15 Europe PMC14 |
| 2017 |
Gould, J., Treyvaud, K., Yelland, L., Anderson, P., Smithers, L., McPhee, A., & Makrides, M. (2017). Seven-year follow-up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA, 317(11), 1173-1175.
DOI Scopus44 WoS37 Europe PMC22 |
| 2017 |
Sullivan, T., Yelland, L., Lee, K., Ryan, P., & Salter, A. (2017). Treatment of missing data in follow-up studies of randomised controlled trials: a systematic review of the literature. Clinical Trials, 14(4), 387-395.
DOI Scopus22 WoS19 Europe PMC11 |
| 2017 |
Dodd, J., Du Plessis, L., Deussen, A., Grivell, R., Yelland, L., Louise, J., . . . Owens, J. (2017). Paternal obesity modifies the effect of an antenatal lifestyle intervention in women who are overweight or obese on newborn anthropometry. Scientific Reports, 7(1), 1557-1-1557-9.
DOI Scopus8 WoS8 Europe PMC5 |
| 2017 |
Zhou, S., Best, K., Gibson, R., McPhee, A., Yelland, L., Quinlivan, J., & Makrides, M. (2017). Study protocol for a randomised controlled trial evaluating the effect of prenatal omega-3 LCPUFA supplementation to reduce the incidence of preterm birth: the ORIP trial. BMJ Open, 7(9), e018360-1-e018360-9.
DOI Scopus18 WoS19 Europe PMC11 |
| 2016 |
Yelland, L., Gajewski, B., Colombo, J., Gibson, R., Makrides, M., & Carlson, S. (2016). Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials. Prostaglandins Leukotrienes and Essential Fatty Acids, 112, 44-49.
DOI Scopus21 WoS18 Europe PMC15 |
| 2016 |
Dodd, J., Newman, A., Moran, L., Deussen, A., Grivell, R., Yelland, L., . . . Robinson, J. (2016). The effect of antenatal dietary and lifestyle advice for women who are overweight or obese on emotional well-being: the LIMIT randomized trial. Acta Obstetricia et Gynecologica Scandinavica, 95(3), 309-318.
DOI Scopus25 WoS21 Europe PMC23 |
| 2016 |
Grivell, R., Yelland, L., Deussen, A., Crowther, C., & Dodd, J. (2016). Antenatal dietary and lifestyle advice for women who are overweight or obese and the effect on fetal growth and adiposity: The LIMIT randomised trial. BJOG: An International Journal of Obstetrics and Gynaecology, 123(2), 233-243.
DOI Scopus31 WoS26 Europe PMC21 |
| 2016 |
Dodd, J., Deussen, A., Mohamad, I., Rifas-Shiman, S., Yelland, L., Louise, J., . . . Robinson, J. (2016). The effect of antenatal lifestyle advice for women who are overweight or obese on secondary measures of neonatal body composition: The LIMIT randomised trial. BJOG: An International Journal of Obstetrics and Gynaecology, 123(2), 244-253.
DOI Scopus25 WoS24 Europe PMC18 |
| 2016 |
Yelland, L. N., Sullivan, T. R., Pavlou, M., & Seaman, S. R. (2016). Response to Klebanoff. Paediatric and Perinatal Epidemiology, 30(2), 206.
DOI |
| 2016 |
Yelland, L., Makrides, M., McPhee, A., Quinlivan, J., & Gibson, R. (2016). Importance of adequate sample sizes in fatty acid intervention trials. Prostaglandins, Leukotrienes and Essential Fatty Acids, 107, 8-11.
DOI Scopus7 WoS6 Europe PMC5 |
| 2016 |
Muhlhausler, B., Yelland, L., McDermott, R., Tapsell, L., McPhee, A., Gibson, R., & Makrides, M. (2016). DHA supplementation during pregnancy does not reduce BMI or body fat mass in children: follow-up of the DHA to Optimize Mother Infant Outcome randomized controlled trial. American Journal of Clinical Nutrition, 103(6), 1489-1496.
DOI Scopus42 WoS38 Europe PMC27 |
| 2016 |
Gould, J., Anderson, A., Yelland, L., Gibson, R., & Makrides, M. (2016). Maternal characteristics influence response to DHA during pregnancy. Prostaglandins, Leukotrienes and Essential Fatty Acids, 108, 5-12.
DOI Scopus15 WoS11 Europe PMC9 |
| 2016 |
Gould, J. F., Treyvaud, K., Yelland, L. N., Anderson, P. J., Smithers, L. G., Gibson, R. A., . . . Makrides, M. (2016). Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial. BMJ Open, 6(5), e011465-1-e011465-9.
DOI Scopus17 WoS15 Europe PMC5 |
| 2016 |
van Dijk, S., Zhou, J., Peters, T., Buckley, M., Sutcliffe, B., Oytam, Y., . . . Muhlhausler, B. (2016). Effect of prenatal DHA supplementation on the infant epigenome: results from a randomized controlled trial. Clinical Epigenetics, 8(1), 114-1-114-13.
DOI Scopus70 WoS50 Europe PMC41 |
| 2015 |
Martin, K. E., Grivell, R. M., Yelland, L. N., & Dodd, J. M. (2015). The influence of maternal BMI and gestational diabetes on pregnancy outcome. Diabetes Research and Clinical Practice, 108(3), 508-513.
DOI Scopus64 WoS50 Europe PMC33 |
| 2015 |
Yelland, L., Sullivan, T., Voysey, M., Lee, K., Cook, J., & Forbes, A. (2015). Applying the intention-to-treat principle in practice: guidance on handling randomisation errors. Clinical Trials, 12(4), 418-423.
DOI Scopus49 WoS45 Europe PMC29 |
| 2015 |
Gould, J., Anderson, A., Yelland, L., Smithers, L., Skeaff, C., Gibson, R., & Makrides, M. (2015). Association of cord blood vitamin D at delivery with postpartum depression in Australian women. Australian and New Zealand Journal of Obstetrics and Gynaecology, 55(5), 446-452.
DOI Scopus25 WoS21 Europe PMC11 |
| 2015 |
Dodd, J., Kannieappan, L., Grivell, R., Deussen, A., Moran, L., Yelland, L., & Owens, J. (2015). Effects of an antenatal dietary intervention on maternal anthropometric measures in pregnant women with obesity. Obesity, 23(8), 1555-1562.
DOI Scopus11 WoS9 Europe PMC7 |
| 2015 |
Dodd, J. M., Ahmed, S., Karnon, J., Umberger, W., Deussen, A. R., Tran, T., . . . Robinson, J. S. (2015). The cost-effectiveness of providing antenatal lifestyle advice for women who are overweight or obese: the LIMIT randomised trial. BMC Obesity, 2(1), 14-1-14-9.
DOI Scopus16 Europe PMC13 |
| 2015 |
Yelland, L., Sullivan, T., Pavlou, M., & Seaman, S. (2015). Analysis of randomised trials including multiple births when birth size is informative. Paediatric and Perinatal Epidemiology, 29(6), 567-575.
DOI Scopus20 WoS19 Europe PMC13 |
| 2015 |
Zhou, S., Skeaff, S., Ryan, P., Doyle, L., Anderson, P., Kornman, L., . . . Makrides, M. (2015). The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo-controlled trial. Trials, 16(1), 563-1-563-9.
DOI Scopus43 WoS33 Europe PMC24 |
| 2015 |
Yelland, L. N., Sullivan, T. R., & Makrides, M. (2015). Accounting for multiple births in randomised trials: a systematic review. Archives of Disease in Childhood. Fetal and Neonatal Edition, 100(2), 116-120.
DOI Scopus16 WoS16 Europe PMC9 |
| 2014 |
Szmeja, M., Cramp, C., Grivell, R., Deussen, A., Yelland, L., & Dodd, J. (2014). Use of a DVD to provide dietary and lifestyle information to pregnant women who are overweight or obese: a nested randomised trial. BMC Pregnancy and Childbirth, 14(1), 409-1-409-11.
DOI Scopus23 WoS18 Europe PMC14 |
| 2014 |
Dodd, J., Cramp, C., Sui, Z., Yelland, L., Deussen, A., Grivell, R., . . . Robinson, J. (2014). The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on maternal diet and physical activity: the LIMIT randomised trial. BMC Medicine, 12(1), 161-1-161-19.
DOI Scopus134 WoS112 Europe PMC85 |
| 2014 |
Dodd, J., McPhee, A., Turnbull, D., Yelland, L., Deussen, A., Grivell, R., . . . Robinson, J. (2014). The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on neonatal health outcomes: the LIMIT randomised trial. BMC Medicine, 12(1), 163-1-163-9.
DOI Scopus70 WoS60 Europe PMC46 |
| 2014 |
Dodd, J., Turnbull, D., McPhee, A., Deussen, A., Grivell, R., Yelland, L., . . . Robinson, J. (2014). Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ, 348(3), 1-12.
DOI Scopus396 WoS330 Europe PMC246 |
| 2014 |
Dodd, J., Turnbull, D., McPhee, A., Deussen, A., Grivell, R., Yelland, L., . . . Robinson, J. (2014). Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. Obstetrical and Gynecological Survey, 69(6), 311-313.
DOI Scopus3 WoS2 |
| 2014 |
Bain, E., Middleton, P., Yelland, L., Ashwood, P., & Crowther, C. (2014). Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial. BJOG, 121(5), 595-603.
DOI Scopus11 WoS9 Europe PMC4 |
| 2014 |
Muhlhausler, B., Gibson, R., Yelland, L., & Makrides, M. (2014). Heterogeneity in cord blood DHA concentration: towards an explanation. Prostaglandins, leukotrienes, and essential fatty acids, 91(4), 135-140.
DOI Scopus24 WoS21 Europe PMC10 |
| 2014 |
Makrides, M., Gould, J., Gawlik, N., Yelland, L., Smithers, L., Anderson, P., & Gibson, R. (2014). Four-year follow-up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA: Journal of the American Medical Association, 311(17), 1802-1804.
DOI Scopus69 WoS55 Europe PMC38 |
| 2013 |
Kannieappan, L., Deussen, A., Grivell, R., Yelland, L., & Dodd, J. (2013). Developing a tool for obtaining maternal skinfold thickness measurements and assessing inter-observer variability among pregnant women who are overweight and obese. BMC Pregnancy and Childbirth, 13(1), 42-48.
DOI Scopus32 WoS26 Europe PMC19 |
| 2013 |
Tu, W., Muhlhausler, B., Yelland, L., & Gibson, R. (2013). Correlations between blood and tissue omega-3 LCPUFA status following dietary ALA intervention in rats. Prostaglandins Leukotrienes and Essential Fatty Acids, 88(1), 53-60.
DOI Scopus45 WoS40 Europe PMC29 |
| 2012 |
Crowther, C., Aghajafari, F., Askie, L., Asztalos, E., Brocklehurst, P., Bubner, T., . . . Zhang, Y. (2012). Repeat prenatal corticosteroid prior to preterm birth: a systematic review and individual participant data meta-analysis for the PRECISE study group (prenatal repeat corticosteroid international IPD study group: assessing the effects using the best level of evidence) - study protocol. Systematic Reviews, 1(12), 1-10.
DOI Scopus16 WoS16 Europe PMC9 |
| 2012 |
Piteo, A., Yelland, L., & Makrides, M. (2012). Does maternal depression predict developmental outcome in 18 month old infants?. Early Human Development, 88(8), 651-655.
DOI Scopus49 WoS40 Europe PMC27 |
| 2012 |
Zhou, S., Yelland, L., McPhee, A., Quinlivan, J., Gibson, R., & Makrides, M. (2012). Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition, 95(6), 1378-1384.
DOI Scopus112 WoS90 Europe PMC63 |
| 2012 |
Crowther, C., Hague, W., Middleton, P., Baghurst, P., McPhee, A., Tran, T., . . . Robinson, J. (2012). The IDEAL study: investigation of dietary advice and lifestyle for women with borderline gestational diabetes: a randomised controlled trial - study protocol. BMC Pregnancy and Childbirth, 12(106), 2-8.
DOI Scopus15 WoS13 Europe PMC7 |
| 2011 |
Makrides, M., Yelland, L., & Gibson, R. (2011). Maternal depression and child development after prenatal DHA supplementation: Reply. JAMA - Journal of the American Medical Association, 305(4), 360-361.
DOI Europe PMC4 |
| 2011 |
Yelland, L., Salter, A., & Ryan, P. (2011). Performance of the modified poisson regression approach for estimating relative risks from clustered prospective data. American Journal of Epidemiology, 174(8), 984-992.
DOI Scopus310 WoS263 Europe PMC239 |
| 2011 |
Yelland, L., Salter, A., & Ryan, P. (2011). Relative risk estimation in randomized controlled trials: A comparison of methods for independent observations. The International Journal of Biostatistics, 7(1), 2-33.
DOI Scopus30 WoS37 |
| 2011 |
Yelland, L., Salter, A., & Ryan, P. (2011). Relative risk estimation in cluster randomized trials: A comparison of generalized estimating equation methods. The International Journal of Biostatistics, 7(1), 2-28.
DOI Scopus16 WoS2 |
| 2011 |
Yelland, L., Salter, A., Ryan, P., & Makrides, M. (2011). Analysis of binary outcomes from randomised trials including multiple births: when should clustering be taken into account?. Paediatric and Perinatal Epidemiology, 25(3 Sp Iss), 283-297.
DOI Scopus20 WoS19 Europe PMC18 |
| 2011 |
Yelland, L., Salter, A., Ryan, P., & Laurence, C. (2011). Adjusted intraclass correlation coefficients for binary data: methods and estimates from a cluster-randomized trial in primary care. Clinical Trials, 8(1), 48-58.
DOI Scopus31 WoS26 Europe PMC25 |
| 2010 |
Makrides, M., Gibson, R., McPhee, A., Yelland, L., Quinlivan, J., Ryan, P., . . . Griffith, E. (2010). Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial. Jama-journal of the American Medical Association, 304(15), 1675-1683.
DOI Scopus461 WoS394 Europe PMC290 |
| 2010 |
Yelland, L., Gialamas, A., Laurence, C., Willson, K., Ryan, P., Beilby, J., . . . Worley, P. (2010). Assessing agreement between point of care and pathology laboratory results for INR: experiences from the Point of Care Testing in General Practice Trial. Pathology, 42(2), 155-159.
DOI Scopus8 WoS7 Europe PMC5 |
| 2010 |
Gialamas, A., Laurence, C., Yelland, L., Tideman, P., Worley, P., Shephard, M., . . . Beilby, J. (2010). Assessing agreement between point of care and laboratory results for lipid testing from a clinical perspective. Clinical Biochemistry, 43(4-5), 515-518.
DOI Scopus16 WoS16 Europe PMC12 |
| 2010 |
Laurence, C., Gialamas, A., Bubner, T., Yelland, L., Willson, K., Ryan, P., . . . Worley, P. (2010). Patient satisfaction with point-of-care testing in general practice. British Journal of General Practice, 60(572), 166-171.
DOI Scopus53 WoS67 Europe PMC50 |
| 2010 |
Makrides, M., Gibson, R., McPhee, A., Yelland, L., Quinlivan, J., & Ryan, P. (2010). Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial (1). Revista Chilena de Obstetricia y Ginecologia, 75(6), 422-424. |
| 2009 |
Gialamas, A., Yelland, L., Ryan, P., Willson, K., Laurence, C., Bubner, T., . . . Beilby, J. (2009). Does point-of-care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial. Medical Journal of Australia, 191(9), 487-491.
DOI Scopus68 WoS64 Europe PMC42 |
| 2009 |
Bubner, T., Laurence, C., Gialamas, A., Yelland, L., Ryan, P., Willson, K., . . . Beilby, J. (2009). Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial. Medical Journal of Australia, 190(11), 624-626.
DOI Scopus59 WoS57 Europe PMC34 |
| 2009 |
Laurence, C., Gialamas, A., Yelland, L., Bubner, T., Ryan, P., Willson, K., . . . Beilby, J. (2009). Erratum: A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - Rationale, design and baseline characteristics (Trials)). Trials, 10(1), 3 pages.
DOI |
| 2008 |
Laurence, C., Gialamas, A., Yelland, L., Bubner, T., Ryan, P., Willson, K., . . . Beilby, J. (2008). A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics. Trials, 9(50), www1-www14.
DOI Scopus41 WoS45 Europe PMC29 |
| 2008 |
Yelland, L., Burns, J., Sims, N., Salter, A., & White, J. (2008). Inter- and intra-subject variability in ethanol pharmacokinetic parameters: effects of testing interval and dose.. Forensic Science International, 175(1), 65-72.
DOI Scopus11 WoS8 |
| 2007 |
Broadhurst, N., Barton, C., Rowett, D., Yelland, L., Matin, D., Gialamas, A., & Beilby, J. (2007). A before and after study of the impact of academic detailing on the use of diagnostic imaging for shoulder complaints in general practice. BMC Family Practice, 8(1), WWW 1-WWW 8.
DOI Scopus15 WoS14 Europe PMC10 |
| 2007 |
Breed, W., Bauer, M., Wade, R., Thitipramote, N., Suwajarat, J., & Yelland, L. (2007). Intra-individual variation in sperm tail length in murine rodents. Journal of Zoology, 272(3), 299-304.
DOI Scopus22 WoS20 |
| 2006 |
Broadhurst, N., Barton, C., Yelland, L., Martin, D., & Beilby, J. (2006). Managing shoulder pain in general practice: The value of academic detailing. Australian Family Physician, 35(9), 751-752.
Scopus9 Europe PMC6 |
| 2006 |
Nelson, M., Reid, C., Ryan, P., Willson, K., & Yelland, L. (2006). Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Medical Journal of Australia, 185(9), 487-489.
DOI Scopus104 WoS89 Europe PMC64 |
| 2006 |
Broadhurst, N., Barton, C., Rowett, D., Yelland, L., Martin, D., Gialamas, A., & Beilby, J. (2006). Academic detailing and informed use of imaging of the shoulder in general practice. Australasian Musculoskeletal Medicine, 11(1), 28-35. |
| 2005 |
Barnden, L., Behin-Ain, S., Kwiatek, R., Casse, R., & Yelland, L. (2005). Age related preservation and loss in optimized brain SPECT. Nuclear Medicine Communications, 26(6), 497-503.
DOI Scopus11 WoS8 Europe PMC7 |
